Checkpoint Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2016

Stockholders' Equity Note [Abstract]

Nonvested Restricted Stock Shares Activity [Table Text Block]

The following table summarizes restricted stock award activity for the nine months ended September 30, 2016.

			Weighted Average Grant Date
	Number of Units		Fair Value
Nonvested at December 31, 2015		2,500,000	$	1.73
Granted		238,000		4.40
Vested		(515,625)		0.07
Nonvested at September 30, 2016		2,222,375	$	2.41

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of warrant activities for six months ended September 30, 2016 is presented below:


	Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2015		4,286,782	$	6.61		5.68
Granted		44,324		7.00		4.40
Outstanding as of September 30, 2016		4,331,106	$	6.62		4.92

Schedule of Share-based Compensation, Activity [Table Text Block]

The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2016 (in thousands).

	Three Months Ended September 30,				Nine Months Ended September 30,
	2016		2015		2016		2015
Research and development	$	411	$	2,071	$	1,635	$	2,084
General and administrative		349		-		1,016		-
Total stock-based compensation expense	$	760	$	2,071	$	2,651	$	2,084

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details